Article

eNACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first episode psychosis

2019-10-11

Abstract excerpt

<title>Abstract</title> <p>Background First episode psychosis (FEP) may lead to a progressive, potentially disabling and lifelong chronic illness; however, evidence suggests that the illness course can be improved if appropriate treatments are given at the early stages. Nonetheless, the efficacy of antipsychotic medications is suboptimal, particularly for negative and cognitive symptoms, and more efficacious and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8eb73890-6b88-5b44-92d2-37923ae32677
DOI: 10.21203/rs.2.12681/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

eNACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first episode psychosisDOI 10.21203/rs.2.12681/v2Read

Nutraceuticals and phytoceuticals in the treatment of schizophrenia: a systematic review and network meta-analysisSemantic proximity Read

Central oxidative stress and early vocational outcomes in first episode psychosis: A 7-Tesla Magnetic Resonance Spectroscopy study of glutathioneSemantic proximity Read

[Preventive treatments in schizophrenia].Semantic proximity Read

Polyunsaturated fatty acids (PUFA) Bimodality Unmasks xCT-Deficient Schizophrenia: Evidence of Two Distinct BiotypesSemantic proximity Read

Long-term N-Acetylcysteine Treatment Accelerates Improvement in Patient-Reported Outcomes for COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled TrialSemantic proximity Read

Nonmedical Interventions for Schizophrenia: A Review of Diet, Exercise and Social RolesSemantic proximity Read

Comparative efficacy of pharmacological and non-pharmacological adjunctive treatments for prominent or persistent negative symptoms of schizophrenia: a systematic review and network meta-analysisSemantic proximity Read

Early intervention and the treatment of prodrome in schizophrenia: a review of recent developments.Semantic proximity Read

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: A trial designSemantic proximity Read

The general neurocognitive decline in patients with methamphetamine (MA) use and transient MA-induced psychosis is primarily determined by oxidative and AGE-RAGE stressSemantic proximity Read

Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.Semantic proximity Read

Amisulpride Augmentation Therapy Improves Cognitive Performance and Psychopathology in Clozapine-resistant Treatment-refractory Schizophrenia (CTRS): a 12-week Randomized, Double-blind, Placebo-controlled TrialSemantic proximity Read